These results indicate that AP4 inhibits caspase‐dependent apoptosis induced by various chemotherapeutic drugs via increasing the expression of LAPTM4B, providing further evidence that AP4 may change the chemotherapy sensitivity of HCC by inhibiting drug‐induced apoptosis via a caspase‐dependent pathway. Here, LAPTM4B is linked to hepatocellular carcinoma.